Stock listing

TASE:TEVA Teva Pharmaceutical Industries Limited מניה‎

Home listing (TASE) of Teva Pharmaceutical Industries Limited

Follow Teva Pharmaceutical Industries Limited into a list and get an email when it puts out news.

Share price · TASE:TEVA

12,930 ILA (agorot) 0 (0.0%)

Close on Oct 19, 2026

Past 3 months +21.9% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
12,820 – 13,050 ILA (agorot)Oct 19, 2026
Volume
1.06M sharesOct 19, 2026
Teva Pharmaceutical Industries Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TASE:TEVA · Home12,930 ILA (agorot)0 (0.0%)1,057,34213,00013,05012,82012,930Close on Oct 19, 2026
NYSE:TEVA$41.31 USD-0.19 (-0.5%)3,827,812$41.42$41.88$41.25$41.50Close on Oct 19, 2026
B3:T1EV34104.72 BRL-0.08 (-0.1%)11102.70104.72102.70104.80Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · TASE:TEVA · ILA (agorot), adjusted for splits

DayCloseChange%OpenHighLowVolume
12,93000.0%13,00013,05012,8201,057,342
12,930-10-0.1%12,56012,99012,5401,008,583
12,940+200+1.6%12,73012,94012,620971,415
12,740+110+0.9%12,61012,78012,530980,586
12,630+630+5.3%12,61012,73012,5501,611,466
12,000+230+2.0%11,98012,06011,910671,471
11,770-220-1.8%11,88011,99011,7701,291,493
11,990-20-0.2%11,90012,09011,8201,153,909
12,010+10+0.1%12,20012,20012,0001,216,909
12,000-160-1.3%12,12012,15012,000853,894
12,16000.0%12,16012,16012,1600
12,160-150-1.2%12,20012,30012,140892,287
12,310+340+2.8%12,10012,31012,0801,011,870
11,970+130+1.1%12,00012,04011,920879,177
11,840-210-1.7%11,90011,93011,750669,308
12,05000.0%12,05012,05012,0500
12,050-10-0.1%11,76012,06011,7301,570,387
12,060+20+0.2%11,89012,08011,7801,262,779
12,040+80+0.7%12,04012,15011,8701,541,251
11,96000.0%11,96011,96011,9600
11,96000.0%11,96011,96011,9600
11,960+160+1.4%11,78011,96011,6001,562,605
11,800+90+0.8%11,90011,99011,6401,135,971
11,710+170+1.5%11,69011,90011,6601,124,143
11,540+420+3.8%11,19011,60011,180950,706
11,12000.0%11,12011,12011,1200
11,120-10-0.1%11,20011,26011,0301,052,520
11,130+210+1.9%11,07011,25010,9601,048,196
10,920+10+0.1%10,92011,02010,6801,086,826
10,910-50-0.5%10,97011,05010,820499,288
10,960-40-0.4%11,09011,09010,900473,654
11,000-10-0.1%11,31011,45010,970983,311
11,010-10-0.1%10,87011,53010,8201,791,302
11,020+310+2.9%10,82011,03010,7801,141,409
10,710-320-2.9%10,94011,00010,660905,060
11,030-180-1.6%11,02011,14010,9801,399,391
11,210+50+0.4%11,16011,28011,120812,651
11,160-50-0.4%11,25011,44011,010740,192
11,210+120+1.1%11,09011,23011,0501,192,310
11,090+70+0.6%11,18011,22011,040727,266
11,020-80-0.7%11,03011,07010,930285,212
11,100-110-1.0%11,15011,19011,030625,182
11,210+130+1.2%10,95011,24010,850937,718
11,080+270+2.5%10,92011,08010,720750,535
10,810+110+1.0%10,79010,86010,650620,299
10,700-250-2.3%10,89010,92010,670587,382
10,950-70-0.6%10,90011,10010,870770,113
11,020+20+0.2%10,87011,08010,860693,156
11,000+350+3.3%10,76011,08010,7001,255,242
10,650+150+1.4%10,53010,75010,450920,617
10,500+110+1.1%10,47010,50010,400277,587
10,390-40-0.4%10,43010,50010,2903,144,670
10,430+80+0.8%10,19010,43010,180974,961
10,350-80-0.8%10,41010,49010,300756,460
10,430-440-4.0%10,83010,86010,380936,895
10,870+190+1.8%10,74010,97010,740672,031
10,680+120+1.1%10,56010,97010,4901,803,433
10,560+975+10.2%9,690.0010,7609,604.002,354,552
9,585.00+85+0.9%9,451.009,677.009,450.00831,774
9,500.00-80-0.8%9,550.009,624.009,465.001,193,392
9,580.00+47+0.5%9,628.009,669.009,535.001,325,339
9,533.0000.0%9,533.009,533.009,533.000
9,533.00-85-0.9%9,580.009,645.009,396.001,061,041
9,618.00-24-0.2%9,510.009,641.009,409.001,288,336
9,642.00-93-1.0%9,759.009,930.009,642.00759,073
Ticker
TASE:TEVA
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
TASE
Currency
ILA

What changed lately

Calls

Replays

  • Teva Pharmaceutical Industries (TASE:TEVA) Q2 2026 Earnings Call

    Wed, Jul 29, 2026 · 8:00 AM ET

    Watch Transcript

  • Teva Pharmaceutical Industries (TASE:TEVA) Q1 2026 Earnings Call

    Wed, Apr 29, 2026 · 8:00 AM ET

    Watch Transcript

  • Teva Pharmaceutical Industries (TASE:TEVA) Q4 2025 Earnings Call

    Wed, Jan 28, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates

Oct 1, 2026

Closed 12,160 (-1.2%) on Oct 1, 2026

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

Sep 28, 2026

Closed 11,970 (+1.1%) on Sep 29, 2026

Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET

Sep 23, 2026

Closed 12,050 (-0.1%) on Sep 24, 2026

Teva Releases Q3 2026 Aide Memoire

Sep 23, 2026

Closed 12,050 (-0.1%) on Sep 24, 2026

Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy

Sep 14, 2026

Closed 11,540 (+3.8%) on Sep 14, 2026

Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes

Sep 10, 2026

Closed 11,120 (-0.1%) on Sep 10, 2026

Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome

Jun 18, 2026

Teva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care

Jun 8, 2026

Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease Chorea

Jun 5, 2026

Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®

Jun 4, 2026

All Teva Pharmaceutical Industries Limited news

Financings

  • Senior notes

    Sep 10, 2026

    Announced: about US$4.9B

    Use of proceeds: Redeem certain existing notes, pay related fees and expenses, and general corporate purposes including repaying outstanding debt

    Announced Sep 10, 2026

Read by 6ix AI from the company's releases

Decks

Teva Pharmaceutical Industries Limited on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
56 in the last 12 months · 100 in all · newest Oct 1, 2026 · oldest 2025
Calls
14 calls with a replay · 14 with a transcript · latest Jul 29, 2026
Decks
132 decks · latest Oct 9, 2026

Where Teva Pharmaceutical Industries Limited is listed

ListingExchangeCountryCurrency
TASE:TEVA · Home listing · This pageTASEIsraelILA
NYSE:TEVANYSEUnited StatesUSD
gettex:TEVgettexGermanyEUR
Frankfurt:TEVFrankfurtGermanyEUR
Tradegate:TEVTradegateGermanyEUR
BOATS:TEVABOATSUnited StatesUSD
OTC:TEVJFOTCUnited StatesUSD
LS Exchange:883035LS ExchangeGermanyEUR
B3:T1EV34B3BrazilBRL
BMV:TEVANBMVMexicoMXN
VIE:TEVAViennaAustriaEUR
BX Swiss:TEVBX SwissSwitzerlandCHF
LSIN:0LERLSINUnited KingdomUSD
Stuttgart:TEVStuttgartGermanyEUR
Hanover:TEVHanoverGermanyEUR
Lang & Schwarz:883035Lang & SchwarzGermanyEUR
BSESOF:TEVBSESOFBulgariaEUR
Dusseldorf:TEVDusseldorfGermanyEUR
Hamburg:TEVHamburgGermanyEUR
Munich:TEVMunichGermanyEUR

Log in to ask 6ix AI your own questions about Teva Pharmaceutical Industries Limited.